CERS Gets BARDA Funding, EPZM Abuzz, ZSAN Awaits Data In Q1 2017 - Nasdaq

CERS Gets BARDA Funding, EPZM Abuzz, ZSAN Awaits Data In Q1 2017 Nasdaq (RTTNews.com) - Cerus Corp. ( CERS ) has inked a 5-year contract with the Biomedical Advanced Research and Development Authority for potential funding of up to approximately $180 million for its anticipated Phase III clinical studies for the INTERCEPT ... and more »

from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNFGDe9ySigcVaTY4_bz3YDOqjkgSw&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779135788804&ei=tzdoV4DPOcSA3QGIqIGgDQ&url=http://www.nasdaq.com/article/cers-gets-barda-funding-epzm-abuzz-zsan-awaits-data-in-q1-2017-20160619-00045
via IFTTT